Safety of Sodium/Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes and CKD

Cromer SJ, Tesfaye H, Cho H, Wexler DJ, Ortega-Montiel J, Schmedt N, Shay CM, Paik JM, Patorno E. Effects of Empagliflozin on Cardiovascular Outcomes Are[...]

Haridas K, Wei J, Lei L, Pham D, Jackson N, Shen N. Real-World Outcomes of Telemedicine Shared Medical Appointments in Obesity Management. Obes Sci Pract.[...]

Sharma A, Johnson M, Kim H, Kumthekar P, Yogendran L, Siegel C, Lwin Z, Koekkoek JAF, Leng L, Balogun J, Philip J. Neuropalliative Care in[...]